Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
The Lancet. Oncology
|
May 19, 2022
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study
Marjorie G Zauderer, Peter W Szlosarek, Sylvestre Le Moulec, et al.
Journal of Hematology & Oncology
|
January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
Jorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 9, 2025
ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress
Jenna L Carter, Yongwei Su, Eman T Al-Antary, et al.
Bone Marrow Transplantation
|
April 7, 2021
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data
Talha Badar, Aniko Szabo, Mark Litzow, et al.
Nano Letters
|
April 3, 2009
Electroluminescence from ZnO/Si-nanotips light-emitting diodes
Ya-Ping Hsieh, Hsin-Yi Chen, Ming-Zhang Lin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 16, 2020
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin
Talha Badar, Aniko Szabo, Martha Wadleigh, et al.
Cancer
|
December 9, 2020
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma
Mrinal M Gounder, Priscilla Merriam, Ravin Ratan, et al.
Blood Advances
|
May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab
Talha Badar, Aniko Szabo, Anjali Advani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2021
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study
Erlene K Seymour, Husain Yar Khan, Yiwei Li, et al.
Nature Neuroscience
|
August 6, 2013
Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation
Dongyi Xu, Weiping Shen, Rong Guo, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
The Lancet. Oncology
|
May 19, 2022
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study
Marjorie G Zauderer, Peter W Szlosarek, Sylvestre Le Moulec, et al.
Journal of Hematology & Oncology
|
January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
Jorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 9, 2025
ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress
Jenna L Carter, Yongwei Su, Eman T Al-Antary, et al.
Bone Marrow Transplantation
|
April 7, 2021
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data
Talha Badar, Aniko Szabo, Mark Litzow, et al.
Nano Letters
|
April 3, 2009
Electroluminescence from ZnO/Si-nanotips light-emitting diodes
Ya-Ping Hsieh, Hsin-Yi Chen, Ming-Zhang Lin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 16, 2020
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin
Talha Badar, Aniko Szabo, Martha Wadleigh, et al.
Cancer
|
December 9, 2020
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma
Mrinal M Gounder, Priscilla Merriam, Ravin Ratan, et al.
Blood Advances
|
May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab
Talha Badar, Aniko Szabo, Anjali Advani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2021
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study
Erlene K Seymour, Husain Yar Khan, Yiwei Li, et al.
Nature Neuroscience
|
August 6, 2013
Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation
Dongyi Xu, Weiping Shen, Rong Guo, et al.
Page
of 15